SCHEMBL23241891

SCHEMBL23241891

C[Si](C)(C)c1ccc2nc(-c3ccccc3)cc(-c3ccccc3)c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.57
▸ KDM4E B2RXH2 6/20 0.57
▸ LMNA P02545 5/20 0.57
▸ MAPT P10636 4/20 0.57
▸ NPSR1 Q6W5P4 3/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ RECQL P46063 1/20 0.57
▸ MAPK1 P28482 2/20 0.54
▸ AURKA O14965 1/20 0.52
▸ AURKB Q96GD4 1/20 0.52
▸ ACACA Q13085 2/20 0.51
▸ HPGD P15428 6/20 0.48
▸ HSP90AA1 P07900 3/20 0.48
▸ ELANE P08246 1/20 0.47
▸ THRB P10828 3/20 0.46
▸ ESR1 P03372 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ TOP1 P11387 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23241888 0.90 ALDH1A1 (0.55) ALDH1A1KDM4ELMNAMAPTNPSR1
SCHEMBL23267810 0.85 ALDH1A1 (0.46) ALDH1A1KDM4ELMNAMAPTNPSR1
SCHEMBL14666153 0.80 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAMAPTNPSR1
SCHEMBL23268389 0.80 ALDH1A1 (0.39) ALDH1A1KDM4ELMNAMAPTNPSR1
SCHEMBL18698068 0.79 ALDH1A1 (0.85) ALDH1A1KDM4ELMNAMAPTNPSR1
SCHEMBL23267807 0.79 ALDH1A1 (0.38) ALDH1A1KDM4ELMNAMAPTNPSR1
SCHEMBL23241887 0.79 ALOX5 (0.42) ALDH1A1KDM4ELMNAMAPTNPSR1
SCHEMBL13774335 0.79 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAMAPTNPSR1
SCHEMBL19953850 0.79 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAMAPTNPSR1
SCHEMBL23267809 0.77 AURKA (0.39) ALDH1A1KDM4ELMNAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12497418-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-12-16 — — US disclosed
US-20210115077-A1 Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-04-22 — — US disclosed
US-20210115077-A1 Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115077-A1 Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound L1CAM, MSL1, NOM1 ALDH1A1 118/4885KDM4E 3489/4885LMNA 1101/4885
US-12497418-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound L1CAM, MSL1, NOM1 ALDH1A1 139/4885KDM4E 3632/4885LMNA 1037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback